Literature DB >> 29790917

Reply to Garg et al, Smith et al, and Persichino and Miller.

A Clinton White1, Christina M Coyle2, Vedantam Rajshekhar3, Gagandeep Singh4, W Allen Hauser5, Aaron Mohanty1, Hector H Garcia6, Theodore E Nash7.   

Abstract

Mesh：

Year:  2018        PMID： 29790917      PMCID： PMC6454487          DOI： 10.1093/cid/ciy437

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Diagnosis and Treatment of Neurocysticercosis: Issues That Need to Be Addressed.

Authors:  Ravindra Kumar Garg; Hardeep Singh Malhotra; Sudhakar Pandey
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

2.  Antiparasitic Dosing Discrepancy in the 2017 Neurocysticercosis Guidelines.

Authors:  Ethan A Smith; Gregory Marks; Angela Hirai-Yang; Hai Tran
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

3.  Pregnancy Screening and Monitoring of Albendazole Therapy for Neurocysticercosis.

Authors:  Jon G Persichino; Loren G Miller
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

4.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

5.  Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.

Authors:  Hector H Garcia; Isidro Gonzales; Andres G Lescano; Javier A Bustos; Mirko Zimic; Diego Escalante; Herbert Saavedra; Martin Gavidia; Lourdes Rodriguez; Enrique Najar; Hugo Umeres; E Javier Pretell
Journal:  Lancet Infect Dis       Date:  2014-07-03       Impact factor: 25.071

6.  Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.

Authors:  Hector H Garcia; Andres G Lescano; Isidro Gonzales; Javier A Bustos; E Javier Pretell; John Horton; Herbert Saavedra; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Infect Dis       Date:  2016-03-16       Impact factor: 9.079

Review 7.  Disseminated cysticercosis: clinical spectrum, Toll-like receptor-4 gene polymorphisms and role of albendazole: A prospective follow-up of 60 cases with a review of 56 published cases.

Authors:  Abdul Qavi; Ravindra Kumar Garg; Hardeep Singh Malhotra; Amita Jain; Neeraj Kumar; Kiran Preet Malhotra; Pradeep Kumar Srivastava; Rajesh Verma; Praveen Kumar Sharma
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.